A formulation under the form of a powder comprising a controlled release dosage form comprising colchicine, under the form of microparticles having a mean particle size determined by laser light diffraction measurement method equal or greater than 10 μm, comprising a polymeric matrix, wherein the polymeric matrix comprises at least one poly(lactic-co-glycolic acid) copolymer, at least one poly(caprolactone), or at least a mixture of at least a poly(lactic-co-glycolic acid) copolymer and at least a poly(caprolactone) in an amount of greater than 70% by weight, with respect to the total weight of the polymeric matrix.